Skip to main content

and
  1. No Access

    Article

    Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours

    MiR-371a-3p predicts the presence of a macroscopic non-teratomatous germ cell tumour (GCT). We hypothesised that miR-371a-3p can also detect recurrence during active surveillance (AS) of stage I GCT.

    Christian D. Fankhauser, Ailsa J. Christiansen in British Journal of Cancer (2022)

  2. Article

    Open Access

    Excellent survival in relapsed stage I testicular cancer

    Two thirds of patients with germ-cell cancer (GCC) present as clinical stage I (CSI). Following orchiectomy, active surveillance (AS) has become their standard management. However, 15–50% of patients eventuall...

    Philip Speicher, Christian D. Fankhauser, Anja Lorch, Davide Ardizzone in BMC Cancer (2023)

  3. Article

    Open Access

    Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database

    Active surveillance after orchiectomy is the preferred management in clinical stage I (CSI) germ-cell tumours (GCT) associated with a 15 to 30% relapse rate.

    Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, Di Maria Jiang in British Journal of Cancer (2023)